Skip to main content

Table 4 Characteristics of the 15 intermediate-risk EEC patients with recurrence

From: Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?

Group Age range (years) Tumor grade Myometrial invasion Tumor maximum diameter (mm) Lesion location Treatment after surgery Interval between initial surgery and recurrence(months) Site of recurrence Treatment after recurrence Outcome Observation time (months)
  50–55 G1 <50% 20 fundus none 60 distant(lung involved) chemotherapy alive 75
  70–75 G2 <50% 40 diffuse lesion none 35 distant(lung involved) palliative treatment died of recurrence 66
LND 50–55 G1 <50% 20 side wall none 12 local chemotherapy + radiotherapy alive 20
n = 6 65–70 G1 <50% 30 left cornua none 38 local traditional Chinese medicine alive 41
  65–70 G2 <50% 20 side wall none 62 local + distant chemotherapy died of recurrence 126
  60–65 G1 <50% 26 left cornua none 23 local radiotherapy alive 48
  65–70 G2 <50% 25 side wall none 57 local + distant unknown died of recurrence 57
  50–55 G1 <50% 25 side wall chemotherapy + radiotherapy 5 local radiotherapy alive 85
  50–55 G1 <50% 32 side wall none 25 local radiotherapy alive 66
LND omitted 65–70 G1 <50% 24 fundus none 34 distant surgery alive 47
n = 9 55–60 G1 <50% 20 left cornua none 8 local surgery + chemotherapy alive 76
  55–60 G1 <50% 50 side wall chemotherapy 12 distant(lung involved) chemotherapy alive 49
  45–50 G1 <50% 22 lower uterine segment chemotherapy 12 distant chemotherapy died of recurrence 99
  65–70 G2 <50% 30 side wall none 8 distant chemotherapy died of recurrence 43
  65–70 G2 none 50 right cornua none 7 distant chemotherapy died of recurrence 30
  1. LND lymph node dissection